Combination Therapies in Chronic Myeloid Leukemia for Potential Treatment-Free Remission: Focus on Leukemia Stem Cells and Immune Modulation

Although tyrosine Kinase Inhibitors (TKI) has revolutionized the treatment of chronic myeloid leukemia (CML), patients are not cured with the current therapy modalities. Also, the more recent goal of CML treatment is to induce successful treatment-free remission (TFR) among patients achieving durabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Mu, Hui, Zhu, Xiaojian, Jia, Hui, Zhou, Lu, Liu, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155539/
https://www.ncbi.nlm.nih.gov/pubmed/34055612
http://dx.doi.org/10.3389/fonc.2021.643382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155539/
https://www.ncbi.nlm.nih.gov/pubmed/34055612
http://dx.doi.org/10.3389/fonc.2021.643382

Ejemplares similares